Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04339699 · ClinicalTrials.gov registry record · NA

NobleStitch EL STITCH Trial is a PFO Comparative Trial

A NA study of Stroke, Ischemic and Foramen Ovale, Patent, sponsored by Nobles Medical Technologies II.

Recruiting
Registry status
NA
Development phase
640
Enrollment target
2
Study locations

NCT04339699 is a NA study of Stroke, Ischemic and Foramen Ovale, Patent that is actively recruiting participants, run by Nobles Medical Technologies II. The registered enrollment target is 640 participants, above the 270-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (137% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04339699, a NA study of Stroke, Ischemic and Foramen Ovale, Patent, is actively recruiting participants, sponsored by Nobles Medical Technologies II.

RECRUITING
Registry status
NA
Development phase
640 participants
Enrollment target
2
Study locations

Study Summary

STITCH - Prospective Multi-Center Comparative Parallel Concurrent Study of the NobleStitch™ EL versus FDA-approved Amplatzer Occluder device for closure of Patent Foramen Ovale to prevent recurrent Ischemic stroke.

Interventions

  • DEVICE NobleStitch™EL Suture Mediated Closure System
  • DEVICE Amplatzer PFO Occluder

Study Locations (2)

Arizona

  • TMC HealthCare - Tucson

Lazio

  • Ospedale S. Eugenio - Rome

Trial Details

FieldValue
Enrollment Target 640 participants
Start Date 2021-01-01
Est. Completion 2027-06-30
Phase NA

Sponsor

Nobles Medical Technologies II

1 total trials

What the Registry Record Tells You About NCT04339699

The ClinicalTrials.gov registry entry for NCT04339699 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 640 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 270-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (137% higher). The listed sponsor is Nobles Medical Technologies II, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke, Ischemic appearing as the primary indexed condition, and to 2 interventions - of which NobleStitch™EL Suture Mediated Closure System is the first listed.

NCT04339699 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Lazio.

Frequently Asked Questions

What is clinical trial NCT04339699 about?

NCT04339699 is a clinical study titled "NobleStitch EL STITCH Trial is a PFO Comparative Trial". STITCH - Prospective Multi-Center Comparative Parallel Concurrent Study of the NobleStitch™ EL versus FDA-approved Amplatzer Occluder device for closure of Patent Foramen Ovale to prevent recurrent Ischemic stroke.

What is the current status of trial NCT04339699?

This trial is currently recruiting. It is a NA study. The enrollment target is 640 participants. The study started on 2021-01-01. Estimated completion is 2027-06-30.

What conditions does trial NCT04339699 study?

This clinical trial studies the following conditions: Stroke, Ischemic, Foramen Ovale, Patent.

What interventions are being tested in trial NCT04339699?

The interventions under investigation include: NobleStitch™EL Suture Mediated Closure System (DEVICE), Amplatzer PFO Occluder (DEVICE).

Who is sponsoring clinical trial NCT04339699?

This trial is sponsored by Nobles Medical Technologies II, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04339699 being conducted?

This trial has 2 study locations across Arizona, Lazio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke, Ischemic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.